BGI Stakes a Claim

China's BGI announced today that it is paying nearly $118 million in cash to acquire Complete Genomics — a move that has a number of industry observers speculating about the motivation for the deal and its broader impact on the sequencing services market.

At Omics Omics, Keith Robison asks, "what is BGI Shenzhen getting out of all this and how does it make sense?"

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.